盐酸普拉克索

更新时间:2024-01-02 16:04:53

盐酸普拉克索结构式
盐酸普拉克索结构式
品牌特惠专场
常用名 盐酸普拉克索 英文名 Pramipexole dihydrochloride
CAS号 104632-25-9 分子量 284.249
密度 N/A 沸点 378ºC at 760 mmHg
分子式 C10H19Cl2N3S 熔点 288-290ºC
MSDS 美版 闪点 182.4ºC

 盐酸普拉克索用途


Pramipexole双盐酸盐是部分和完全的D2S,D2L,D3和D4受体激动剂, Ki分别为3.9,2.2,0.5和5.1 nM。

 盐酸普拉克索名称

中文名 盐酸普拉克索
英文名 pramipexole hydrochloride anhydrous
中文别名 S(-)-2-氨基-6-正丙氨基-4,5,6,7-四氢苯并噻唑二盐酸盐 | (S)-普拉克索二盐酸化物
英文别名 更多

 盐酸普拉克索物理化学性质

沸点 378ºC at 760 mmHg
熔点 288-290ºC
分子式 C10H19Cl2N3S
分子量 284.249
闪点 182.4ºC
精确质量 283.067688
PSA 79.18000
LogP 4.15830
外观性状 白色结晶粉末
蒸汽压 6.49E-06mmHg at 25°C
储存条件 Desiccate at RT

 盐酸普拉克索安全信息

危害码 (欧洲) Xi
危险品运输编码 NONH for all modes of transport
海关编码 2934999090

 盐酸普拉克索合成线路

~84%

盐酸普拉克索结构式

盐酸普拉克索

104632-25-9

文献:INSTYTUT FARMACEUTYCZNY Patent: WO2007/75095 A1, 2007 ; Location in patent: Page/Page column 7 ;

~72%

盐酸普拉克索结构式

盐酸普拉克索

104632-25-9

文献:Ravinder; Rajeswar Reddy; Panasa Reddy; Bandichhor, Rakeshwar Tetrahedron Letters, 2013 , vol. 54, # 36 p. 4908 - 4913

~98%

盐酸普拉克索结构式

盐酸普拉克索

104632-25-9

文献:Helm AG; CF Pharma Gyogyszergyarto Kft. Patent: EP1878731 A1, 2008 ; Location in patent: Page/Page column 11 ;

~85%

盐酸普拉克索结构式

盐酸普拉克索

104632-25-9

文献:Helm AG; CF Pharma Gyogyszergyarto Kft. Patent: EP1878731 A1, 2008 ; Location in patent: Page/Page column 11 ;

~%

盐酸普拉克索结构式

盐酸普拉克索

104632-25-9

文献:WO2011/21214 A2, ;

~%

盐酸普拉克索结构式

盐酸普拉克索

104632-25-9

文献:WO2011/21214 A2, ;

~%

盐酸普拉克索结构式

盐酸普拉克索

104632-25-9

文献:WO2011/21214 A2, ;

~%

盐酸普拉克索结构式

盐酸普拉克索

104632-25-9

文献:WO2011/21214 A2, ;

~%

盐酸普拉克索结构式

盐酸普拉克索

104632-25-9

文献:WO2011/21214 A2, ;

 盐酸普拉克索海关

海关编码 2934999090
中文概述 2934999090. 其他杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素 品名, 成分含量, 用途
Summary 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

 盐酸普拉克索文献6

更多文献
Pramipexole reduces parkinsonian tremor induced by pilocarpine infusion in the rat striatum.

Pharmacol. Biochem. Behav. 131 , 1-5, (2015)

Pramipexole is widely prescribed for the treatment of Parkinson's disease. This dopamine (DA) receptor agonist has a higher affinity for D3 over D2 receptors. We compared the effect of pramipexole to ...

Alterations of BDNF and trkB mRNA expression in the 6-hydroxydopamine-induced model of preclinical stages of Parkinson's disease: an influence of chronic pramipexole in rats.

PLoS ONE 10(3) , e0117698, (2015)

Our recent study has indicated that a moderate lesion of the mesostriatal and mesolimbic pathways in rats, modelling preclinical stages of Parkinson's disease, induces a depressive-like behaviour whic...

De novo expression of dopamine D2 receptors on microglia after stroke.

J. Cereb. Blood Flow Metab. 35 , 1804-11, (2015)

Dopamine is the predominant catecholamine in the brain and functions as a neurotransmitter. Dopamine is also a potent immune modulator. In this study, we have characterized the expression of dopamine ...

 盐酸普拉克索英文别名

2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N-propyl-, (6S)-, hydrochloride (1:2)
(6S)-4,5,6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine Dihydrochloride
(S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole dihydrochloride
Pramipexole hydrochloride
Pramipexole dihydrochloride
MFCD00876894
(S)-Pramipexole Dihydrochloride
(6S)-N-Propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine dihydrochloride
(S)-N6-Propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine dihydrochloride
Pramipexole (dihydrochloride)
品牌现货直购
推荐供应商:








查看所有供应商和价格请点击:

盐酸普拉克索生产厂家

盐酸普拉克索价格